DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Harbeck N, Iyer S, Turner N. et al.
Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial.
Ann Oncol 2016;
27: 1047-1054
doi:10.1093/annonc/mdw139
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.